FDA PMA for CryoLife’s New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System

CryoLife Receives FDA Premarket Approval (PMA) for New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System (via PR Newswire)

ATLANTA, July 10, 2013 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration (FDA) premarket…